You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

July 20, 2018

PLC Distribution and Marketing of Drugs 2018 – Vietnam Chapter

Practical Law Company

Practical Law has published the 2018 edition of its Distribution and Marketing of Drugs Global Guide, a easily accessible Q&A overview of the key legal issues involved in bringing drugs to market in 29 jurisdictions worldwide. Members of the Tilleke & Gibbins life sciences team wrote the Vietnam chapter of this year’s guide.

The Vietnam chapter provides a high-level overview of the regulatory regime for the distribution and marketing of pharmaceuticals in Vietnam. The distribution section of the guide covers pre-conditions for distribution, including marketing authorization and exceptions; licensing; distribution to consumers; and wholesale distribution. The marketing section summarizes the regulations on marketing to consumers and marketing to professionals, including the types of marketing activities that are permitted and prohibited; restrictions on advertising; and the permissibility of discounts, free samples, and sponsorships.

Tilleke & Gibbins also contributed the Thailand chapter of the guide. To read the Vietnam chapter, please click on the link below.

RELATED INSIGHTS​ 

February 22, 2018
The Indonesia National Agency of Drug and Food Control (NADFC) has issued the nation’s first official guidelines for food recall in the Head of NADFC Regulation No. 22 of 2017, which entered into force on November 28, 2017. The regulation establishes food recall procedures for manufacturers, importers, and distributors who are obligated to recall food products that are not in accordance with requirements set forth in prevailing laws and regulations.
January 24, 2018
On January 18, 2018, the Ministry of Health (MoH) of Vietnam issued Circular No. 01/2018/TT-BYT (Circular 01) on the labeling of pharmaceuticals (referred to hereinafter as “drugs” for brevity). This circular will take effect from June 1, 2018, and will replace the current drug labeling regulations (Circular No. 06/2016/TT-BYT).